Chronic Leukemia Clinical Trials in Stanford

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
S
Phase 2 Fludarabine, Cytoxan and FCCAM <Alemtuzumab> in Untreated B-Cell Chronic Lymphocytic Leukemia - 2011
Completed
Has Results
  • Leukemia
  • +3 more
  • Stanford, California
    Stanford University School of Medicine
2014-09-25
Sep 25, 2014
V
Trial of AVN-944 in Patients With Advanced Hematologic Malignancies
Completed
  • Acute Leukemia
  • +5 more
  • AVN-944 capsules for oral administration
  • Tucson, Arizona
  • +4 more
2011-08-02
Aug 2, 2011